193 related articles for article (PubMed ID: 29737828)
1. Light-Activated ROS-Responsive Nanoplatform Codelivering Apatinib and Doxorubicin for Enhanced Chemo-Photodynamic Therapy of Multidrug-Resistant Tumors.
Wei X; Liu L; Guo X; Wang Y; Zhao J; Zhou S
ACS Appl Mater Interfaces; 2018 May; 10(21):17672-17684. PubMed ID: 29737828
[TBL] [Abstract][Full Text] [Related]
2. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
[TBL] [Abstract][Full Text] [Related]
3. A Polymer Responsive to Reactive Oxygen Species for Safe, Efficient Chemo-Photodynamic Combined Cancer Therapy.
Lu J; Hao N; Sun Q; Liu Z; Liu L; Xu L; He B; Sun C
J Biomed Nanotechnol; 2019 Oct; 15(10):2045-2058. PubMed ID: 31462370
[TBL] [Abstract][Full Text] [Related]
4. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.
Kim Y; Uthaman S; Pillarisetti S; Noh K; Huh KM; Park IK
Acta Biomater; 2020 May; 108():273-284. PubMed ID: 32205212
[TBL] [Abstract][Full Text] [Related]
5. A new NIR-triggered doxorubicin and photosensitizer indocyanine green co-delivery system for enhanced multidrug resistant cancer treatment through simultaneous chemo/photothermal/photodynamic therapy.
Yu Y; Zhang Z; Wang Y; Zhu H; Li F; Shen Y; Guo S
Acta Biomater; 2017 Sep; 59():170-180. PubMed ID: 28629893
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-loaded NaYF4:Yb/Tm-TiO2 inorganic photosensitizers for NIR-triggered photodynamic therapy and enhanced chemotherapy in drug-resistant breast cancers.
Zeng L; Pan Y; Tian Y; Wang X; Ren W; Wang S; Lu G; Wu A
Biomaterials; 2015 Jul; 57():93-106. PubMed ID: 25913254
[TBL] [Abstract][Full Text] [Related]
7. ROS-triggered and regenerating anticancer nanosystem: an effective strategy to subdue tumor's multidrug resistance.
Su Z; Chen M; Xiao Y; Sun M; Zong L; Asghar S; Dong M; Li H; Ping Q; Zhang C
J Control Release; 2014 Dec; 196():370-83. PubMed ID: 25278256
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative effect of pheophorbide a-mediated photodynamic therapy and its synergistic effect with doxorubicin on multiple drug-resistant uterine sarcoma cell MES-SA/Dx5.
Cheung KK; Chan JY; Fung KP
Drug Chem Toxicol; 2013 Oct; 36(4):474-83. PubMed ID: 23560455
[TBL] [Abstract][Full Text] [Related]
9. The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells.
Yoon JH; Yoon HE; Kim O; Kim SK; Ahn SG; Kang KW
Lasers Surg Med; 2012 Jan; 44(1):76-86. PubMed ID: 22246987
[TBL] [Abstract][Full Text] [Related]
10. Long circulating photoactivable nanomicelles with tumor localized activation and ROS triggered self-accelerating drug release for enhanced locoregional chemo-photodynamic therapy.
Uthaman S; Pillarisetti S; Mathew AP; Kim Y; Bae WK; Huh KM; Park IK
Biomaterials; 2020 Feb; 232():119702. PubMed ID: 31896514
[TBL] [Abstract][Full Text] [Related]
11. A New Photosensitized Oxidation-Responsive Nanoplatform for Controlled Drug Release and Photodynamic Cancer Therapy.
Yeh HP; Del Valle AC; Syu MC; Qian Y; Chang YC; Huang YF
ACS Appl Mater Interfaces; 2018 Jun; 10(25):21160-21172. PubMed ID: 29863836
[TBL] [Abstract][Full Text] [Related]
12. A tumor-specific ROS self-supply enhanced cascade-responsive prodrug activation nanosystem for amplified chemotherapy against multidrug-resistant tumors.
Wang J; Zhang H; Lv J; Zheng Y; Li M; Yang G; Wei X; Li N; Huang H; Li T; Qin X; Li S; Wu C; Zhang W; Liu Y; Yang H
Acta Biomater; 2023 Jul; 164():522-537. PubMed ID: 37072069
[TBL] [Abstract][Full Text] [Related]
13. Dual tumor- and subcellular-targeted photodynamic therapy using glucose-functionalized MoS
Xu S; Zhang P; Heing-Becker I; Zhang J; Tang P; Bej R; Bhatia S; Zhong Y; Haag R
Biomaterials; 2022 Nov; 290():121844. PubMed ID: 36302305
[TBL] [Abstract][Full Text] [Related]
14. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
[TBL] [Abstract][Full Text] [Related]
15. Cyclo-γ-polyglutamic acid-coated dual-responsive nanomicelles loaded with doxorubicin for synergistic chemo-photodynamic therapy.
Wang C; Wang B; Zou S; Wang B; Liu G; Zhang F; Wang Q; He Q; Zhang L
Biomater Sci; 2021 Sep; 9(17):5977-5987. PubMed ID: 34338256
[TBL] [Abstract][Full Text] [Related]
16. High Co-loading Capacity and Stimuli-Responsive Release Based on Cascade Reaction of Self-Destructive Polymer for Improved Chemo-Photodynamic Therapy.
Wang M; Zhai Y; Ye H; Lv Q; Sun B; Luo C; Jiang Q; Zhang H; Xu Y; Jing Y; Huang L; Sun J; He Z
ACS Nano; 2019 Jun; 13(6):7010-7023. PubMed ID: 31188559
[TBL] [Abstract][Full Text] [Related]
17. Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy.
Yang B; Wang K; Zhang D; Sun B; Ji B; Wei L; Li Z; Wang M; Zhang X; Zhang H; Kan Q; Luo C; Wang Y; He Z; Sun J
Biomater Sci; 2018 Nov; 6(11):2965-2975. PubMed ID: 30255178
[TBL] [Abstract][Full Text] [Related]
18. Trackable Mitochondria-Targeting Nanomicellar Loaded with Doxorubicin for Overcoming Drug Resistance.
Zhang Y; Zhang C; Chen J; Liu L; Hu M; Li J; Bi H
ACS Appl Mater Interfaces; 2017 Aug; 9(30):25152-25163. PubMed ID: 28697306
[TBL] [Abstract][Full Text] [Related]
19. pH-Responsive Magnetic Mesoporous Silica-Based Nanoplatform for Synergistic Photodynamic Therapy/Chemotherapy.
Tang XL; Jing F; Lin BL; Cui S; Yu RT; Shen XD; Wang TW
ACS Appl Mater Interfaces; 2018 May; 10(17):15001-15011. PubMed ID: 29648437
[TBL] [Abstract][Full Text] [Related]
20. Acid-responsive dextran-based therapeutic nanoplatforms for photodynamic-chemotherapy against multidrug resistance.
Liu L; Bao Y; Zhang Y; Xiao C; Chen L
Int J Biol Macromol; 2020 Jul; 155():233-240. PubMed ID: 32224169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
